PMID: 9483814
Question: Does para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 9483814
Question: Does para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The research question seeks to determine whether the addition of a para-cervical block provides extra benefits during second-trimester abortion induction using gemeprost.
- **Key Information to Identify:** The study's examination of clinical outcomes such as the duration of abortion induction, pain perception, analgesic requirements, and any side effects associated with the use of para-cervical anesthesia.

**2. Evidence Evaluation**
- **Research Results:** The study compared two groups of 10 women each. One group received only Pethidin intravenously and Butylscopolamine rectally, while the other group additionally received a para-cervical block. The findings indicated:
  - The induction to abortion interval was slightly shorter in the para-cervical group, but the difference was not statistically significant.
  - The para-cervical group required more Butylscopolamine.
  - There was no significant difference in Pethidin requirements or pain intensity between the two groups.
  - No side effects from the para-cervical anesthesia were reported.
- **Strength and Reliability:** The study has a small sample size (20 women), which may limit the generalizability and statistical power of the findings.
- **Relevance:** The evidence directly addresses the research question by comparing relevant clinical outcomes between the two groups.

**3. Conclusion**
Based on the evidence, the addition of a para-cervical block does not provide significant advantages in terms of pain management or analgesic requirements during second-trimester abortion induction with gemeprost. While there was a slight reduction in the duration of the procedure, it was not statistically significant, and there was an increased need for Butylscopolamine. Thus, the overall benefit of adding a para-cervical block appears limited.

**4. Final Answer:**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether para-cervical block provides additional benefits when used with gemeprost for second-trimester abortion induction. Key factors to evaluate include:  
- Impact on procedure duration (induction-to-abortion interval).  
- Pain reduction.  
- Analgesic requirements (e.g., Pethidin, Butylscopolamine).  
- Safety (side effects).  

**2. Evidence Evaluation**  
- **Procedure Duration**: The paracervical block group had a numerically shorter induction-to-abortion interval (median 13 vs. 20 hours), but the difference was not statistically significant (NS). Similarly, intervals from last prostaglandin dose or 3 cm cervical dilation were slightly shorter but not significant.  
- **Pain and Analgesics**: Pain scores (Huskisson scale) and Pethidin requirements were similar between groups. However, Butylscopolamine use was higher in the block group (p<0.05), which is a potential disadvantage.  
- **Safety**: No side effects from paracervical block were reported.  
- **Study Limitations**: Small sample size (20 total participants) may limit statistical power.  

The abstract’s conclusion states that paracervical block has "only limited benefit," primarily due to a non-significant trend toward shorter duration in some cases but no impact on pain or analgesic requirements.  

**3. Conclusion**  
While paracervical block showed a trend toward shorter procedure times in some subgroups, the differences were not statistically significant. Pain reduction and analgesic requirements were unchanged, and Butylscopolamine use increased. Since the study did not demonstrate statistically significant advantages in key outcomes, the evidence supports "no" but acknowledges potential minor trends ("maybe"). However, the abstract explicitly concludes that the benefit is "limited," favoring "no" as the most accurate answer.  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether para-cervical block (PCB) provides additional advantages during second-trimester abortion induction with gemeprost. Key factors include impact on abortion duration, pain perception, and analgesic requirements.  

**2. Evidence Evaluation**  
- **Study Design**: Randomized prospective trial comparing PCB (n=10) vs. standard analgesia (n=10) during gemeprost-induced abortion (16–23 weeks).  
- **Outcomes**:  
  - **Abortion Duration**: Median induction-to-abortion interval was shorter with PCB (13 vs. 20 hours), but not statistically significant (NS). Other time intervals (last gemeprost dose to abortion, 3 cm dilatation to abortion) were also slightly shorter with PCB but NS.  
  - **Pain and Analgesia**: No significant difference in pain scores (Huskisson scale) or pethidine use. PCB group required more butylscopolamine (p<0.05).  
  - **Safety**: No PCB-related side effects reported.  
- **Conclusion**: PCB may shorten late-stage abortion duration in some cases but does not reduce pain or systemic analgesic requirements, offering only limited benefit.  

**3. Conclusion**  
The evidence shows PCB does not significantly improve pain control or reduce opioid use, and the observed reduction in abortion duration was not statistically significant. The increased need for butylscopolamine in the PCB group further weakens its perceived benefit. Thus, PCB does not provide clear additional advantages.  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no